CMRX
Chimerix Inc
Halal Rating :
Last Price
$3.59
Last updated:
Market Cap
-
7D Change
8.46%
1 Year Change
286.02%
Company Overview
Industries
Exchange
Next Earnings Date
Chimerix Inc is a biopharmaceutical company focused on developing and commercializing novel medicines to prevent and treat life-threatening diseases. The company's main product is TEMBEXA® (brincidofovir), an FDA-approved antiviral for all age groups for the treatment of smallpox. The company also has several other drug candidates in its development pipeline targeting various diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $26000.0 | $22.91m | - | $-1914000.0 | 0.00% | 8.36% |
| June 30, 2024 | $129000.0 | $20.81m | - | $-2147000.0 | 0.00% | 10.32% |
Company Impact
Help us evaluate Chimerix Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.